Silexion Therapeutics Corp (SLXN) Free cash flow 2023–2025
Silexion Therapeutics Corp (SLXN) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$10.8MFY2025 · since FY2023: -$4.5M → -$10.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$10.8M | -28.6% |
| FY2024 | -$8.4M | -85.4% |
| FY2023 | -$4.5M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More SLXN financial trends
SLXN RevenueSLXN Net incomeSLXN Net marginSLXN Gross profitSLXN Gross marginSLXN Operating incomeSLXN Operating marginSLXN Operating cash flowSLXN Capital expendituresSLXN Return on equitySLXN Stock buybacksSLXN Dividends paidSLXN Total assetsSLXN Total liabilitiesSLXN Shareholders’ equitySLXN overview →